|
1
|
Fan L, Goss PE and Strasser-Weippl K:
Current status and future projections of breast cancer in asia.
Breast Care (Basel). 10:372–378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Soerjomataram I, Dikshit R, Eser
S, Mathers C, Rebelo M, Parkin DM, Forman D and Bray F: Cancer
incidence and mortality worldwide: Sources, methods and major
patterns in GLOBOCAN 2012. Int J Cancer. 136:E359–E386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Peart O: Metastatic breast cancer. Radiol
Technol. 88:519M–539M. 2017.PubMed/NCBI
|
|
4
|
Bushati N and Cohen SM: microRNA
functions. Ann Rev Cell Dev Biol. 23:175–205. 2007. View Article : Google Scholar
|
|
5
|
Samantarrai D, Dash S, Chhetri B and
Mallick B: Genomic and epigenomic cross-talks in the regulatory
landscape of miRNAs in breast cancer. Mol Cancer Res. 11:315–328.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang Q, Wang Y, Hao Y, Juan L, Teng M,
Zhang X, Li M, Wang G and Liu Y: miR2Disease: A manually curated
database for microRNA deregulation in human disease. Nucleic Acids
Res. 37:D98–D104. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Han X, Yan S, Weijie Z, Feng W, Liuxing W,
Mengquan L and Qingxia F: Critical role of miR-10b in transforming
growth factor-β1-induced epithelial-mesenchymal transition in
breast cancer. Cancer Gene Ther. 21:60–67. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ma L, Teruya-Feldstein J and Weinberg RA:
Tumour invasion and metastasis initiated by microRNA-10b in breast
cancer. Nature. 449:682–688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bahena-Ocampo I, Espinosa M,
Ceballos-Cancino G, Lizarraga F, Campos-Arroyo D, Schwarz A,
Maldonado V, Melendez-Zajgla J and Garcia-Lopez P: miR-10b
expression in breast cancer stem cells supports self-renewal
through negative PTEN regulation and sustained AKT activation. EMBO
Rep. 17:648–658. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yue L, Han C, Li Z, Li X, Liu D, Liu S and
Yu H: Fucosyltransferase 8 expression in breast cancer patients: A
high throughput tissue microarray analysis. Histol Histopathol.
31:547–555. 2016.PubMed/NCBI
|
|
11
|
Cheng L, Gao S, Song X, Dong W, Zhou H,
Zhao L and Jia L: Comprehensive N-glycan profiles of hepatocellular
carcinoma reveal association of fucosylation with tumor progression
and regulation of FUT8 by microRNAs. Oncotarget. 7:61199–61214.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen CY, Jan YH, Juan YH, Yang CJ, Huang
MS, Yu CJ, Yang PC, Hsiao M, Hsu TL and Wong CH: Fucosyltransferase
8 as a functional regulator of nonsmall cell lung cancer. Proc Natl
Acad Sci USA. 110:630–635. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Osumi D, Takahashi M, Miyoshi E, Yokoe S,
Lee SH, Noda K, Nakamori S, Gu J, Ikeda Y, Kuroki Y, et al: Core
fucosylation of E-cadherin enhances cell-cell adhesion in human
colon carcinoma WiDr cells. Cancer Sci. 100:888–895. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mehta A, Comunale MA, Rawat S, Casciano
JC, Lamontagne J, Herrera H, Ramanathan A, Betesh L, Wang M, Norton
P, et al: Intrinsic hepatocyte dedifferentiation is accompanied by
upregulation of mesenchymal markers, protein sialylation and core
alpha 1,6 linked fucosylation. Sci Rep. 6:279652016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo D, Guo J, Li X and Guan F:
Differential effects of Pax3 on expression of
polysialyltransferases STX and PST in TGF-β-treated normal murine
mammary gland cells. Exp Biol Med (Maywood). 242:177–183. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Munkley J and Elliott DJ: Hallmarks of
glycosylation in cancer. Oncotarget. 7:35478–35489. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Teng Y and Li X: The roles of HLH
transcription factors in epithelial mesenchymal transition and
multiple molecular mechanisms. Clin Exp Metastasis. 31:367–377.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fkih M'hamed I, Privat M, Ponelle F,
Penault-Llorca F, Kenani A and Bignon YJ: Identification of
miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative
breast cancer biomarkers. Cell Oncol (Dordr). 38:433–442. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stuchlova Horynova M, Raska M, Clausen H
and Novak J: Aberrant O-glycosylation and anti-glycan antibodies in
an autoimmune disease IgA nephropathy and breast adenocarcinoma.
Cell Mol Life Sci. 70:829–839. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ho WL, Hsu WM, Huang MC, Kadomatsu K and
Nakagawara A: Protein glycosylation in cancers and its potential
therapeutic applications in neuroblastoma. J Hematol Oncol.
9:1002016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
de Leoz ML, Young LJ, An HJ, Kronewitter
SR, Kim J, Miyamoto S, Borowsky AD, Chew HK and Lebrilla CB:
High-mannose glycans are elevated during breast cancer progression.
Mol Cell Proteomics. 10:M110.0027172011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kwan JY, Psarianos P, Bruce JP, Yip KW and
Liu FF: The complexity of microRNAs in human cancer. J Radiat Res.
57(Suppl 1): i106–i111. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Piva R, Spandidos DA and Gambari R: From
microRNA functions to microRNA therapeutics: Novel targets and
novel drugs in breast cancer research and treatment (Review). Int J
Oncol. 43:985–994. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Christodoulatos GS and Dalamaga M:
Micro-RNAs as clinical biomarkers and therapeutic targets in breast
cancer: Quo vadis? World J Clin Oncol. 5:71–81. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Min W, Wang B, Li J, Han J, Zhao Y, Su W,
Dai Z, Wang X and Ma Q: The expression and significance of five
types of miRNAs in breast cancer. Med Sci Monit Basic Res.
20:97–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang X, Chen J, Li QK Peskoe SB, Zhang B,
Choi C, Platz EA and Zhang H: Overexpression of α (1,6)
fucosyltransferase associated with aggressive prostate cancer.
Glycobiology. 24:935–944. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Honma R, Kinoshita I, Miyoshi E, Tomaru U,
Matsuno Y, Shimizu Y, Takeuchi S, Kobayashi Y, Kaga K, Taniguchi N
and Dosaka-Akita H: Expression of fucosyltransferase 8 is
associated with an unfavorable clinical outcome in non-small cell
lung cancers. Oncology. 88:298–308. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cheng L, Luo S, Jin C, Ma H, Zhou H and
Jia L: FUT family mediates the multidrug resistance of human
hepatocellular carcinoma via the PI3K/Akt signaling pathway. Cell
Death Dis. 4:e9232013. View Article : Google Scholar : PubMed/NCBI
|
